Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi‐site cohort

Abstract Scalable cognitive paradigms that provide metrics such as the Computerized Cognitive Composite (C3) may be sensitive enough to relate to Alzheimer's disease biomarkers in the preclinical clinically unimpaired (CU) stage. We examined CU older adults (n = 3287) who completed alternate ve...

Full description

Bibliographic Details
Main Authors: Christina B. Young, Elizabeth C. Mormino, Kathleen L. Poston, Keith A. Johnson, Dorene M. Rentz, Reisa A. Sperling, Kathryn V. Papp
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Online Access:https://doi.org/10.1002/dad2.12414